Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use QULIPTA safely and effectively. See full prescribing information for QULIPTA . QULIPTA ® (atogepant) tablets, for oral use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
QULIPTA is indicated for the preventive treatment of migraine in adults.
- generic_name
- atogepant
- product_names
- Atogepant
- ndc
- 0074-7095, 0074-7095-30, 0074-7096, 0074-7096-30, 0074-7096-04, 0074-7094, 0074-7094-30, 0074-7094-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en